4 Lymphoma Clinical Trials in Fullerton, CA (2026)

Q: How do I join a clinical trial in Fullerton?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Fullerton research site will contact you.

Recruiting Lymphoma Studies in Fullerton

NCT06717347Recruiting

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

The purpose of this study is to evaluate if zilovertamab vedotin with standard treatment can help people live longer without the cancer growing or spreading than people who receive standard treatment ...

Fullerton, CAPHASE31,046 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07439653Recruiting

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

A Phase 1/2 study to evaluate safety, tolerability, and anticancer activity of TORL-5-700 as a monotherapy and in combination in R/R NHL...

Fullerton, CAPHASE1155 participantsTORL Biotherapeutics, LLC

View Study Details

NCT07104032Recruiting

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

The purpose of this clinical trial is to evaluate efficacy and safety of tirabrutinib alone compared with rituximab and temozolomide (R-TMZ) combination therapy in participants with Relapsed/Refractor...

Fullerton, CAPHASE3132 participantsOno Pharmaceutical Co., Ltd.

View Study Details

NCT06806033Recruiting

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

The main goal of this trial is to study the frequency and severity of cytokine release syndrome (CRS) in participants with diffuse large B-cell lymphoma (DLBCL) who are using a combination of glofitam...

Fullerton, CAPHASE2100 participantsHoffmann-La Roche

View Study Details

About Lymphoma Clinical Trials in Fullerton

Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.

There are currently 4 lymphoma clinical trials recruiting participants in Fullerton, CA. These studies are seeking a combined 1,433 participants. Research is being sponsored by Merck Sharp & Dohme LLC, TORL Biotherapeutics, LLC, Ono Pharmaceutical Co., Ltd. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lymphoma Clinical Trials in Fullerton — FAQ

Are there lymphoma clinical trials in Fullerton?

Yes, there are 4 lymphoma clinical trials currently recruiting in Fullerton, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fullerton?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fullerton research site will contact you about next steps.

Are clinical trials in Fullerton free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fullerton studies also compensate for your time and travel.

What lymphoma treatments are being tested?

The 4 active trials in Fullerton are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.

Data updated September 1, 2026 from ClinicalTrials.gov